Disease control should be the goal of therapy for WM patients

Lignende værker

• What should be the goal of therapy for Waldenström macroglobulinemia patients? Complete response should be the goal of therapy
  af: Treon, Steven P., et al.
  Udgivet: (2017)
• How I treat rituximab refractory patients with WM
  af: Gavriatopoulou, Maria, et al.
  Udgivet: (2018)
• Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes
  af: Kastritis, Efstathios, et al.
  Udgivet: (2020)
• Should minimal residual disease negativity not be the end point of myeloma therapy?
  af: Sonneveld, Pieter
  Udgivet: (2017)
• Should minimal residual disease negativity be the end point of myeloma therapy?
  af: Anderson, Kenneth C.
  Udgivet: (2017)